94
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE Imaging, Diagnosis, Prognosis

Effect of the p53 Codon 72 and Intron 3Polymorphisms on Non-Small Cell Lung Cancer (NSCLC) Prognosis

, , , , , , & show all
Pages 168-172 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shengxiang Ren, Songwen Zhou, Ling Zhang, Jianfang Xu, Meijun Lv, Jie Zhang, Caicun Zhou & Jie Zhang. (2010) High-Level mRNA of Excision Repair Cross-Complementation Group 1 Gene Is Associated With Poor Outcome of Platinum-Based Doublet Chemotherapy of Advanced Nonsmall Cell Lung Cancer Patients. Cancer Investigation 28:10, pages 1078-1083.
Read now

Articles from other publishers (14)

Sheikh M. Shaffi. 2021. Genetic Polymorphism and cancer susceptibility. Genetic Polymorphism and cancer susceptibility 319 339 .
Christophe Deben, Vanessa Deschoolmeester, Filip Lardon, Christian Rolfo & Patrick Pauwels. (2016) TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value. Critical Reviews in Oncology/Hematology 99, pages 63-73.
Crossref
Huizhong ShenHuizhong Shen. 2016. Polycyclic Aromatic Hydrocarbons. Polycyclic Aromatic Hydrocarbons 23 84 .
B. Heinze, L. J. M. Herrmann, M. Fassnacht, C. L. Ronchi, H. S. Willenberg, M. Quinkler, N. Reisch, M. Zink, B. Allolio & S. Hahner. (2014) Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma. European Journal of Endocrinology 170:5, pages 707-717.
Crossref
Hung-Yu Lin, Ming-Chang Yang, Chun-Hsiung Huang, Wen-Jen Wu, Tsan-Jung Yu & For-Wey Lung. (2013) Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. Urologic Oncology: Seminars and Original Investigations 31:7, pages 1231-1241.
Crossref
Pascal Andujar, Jean-Claude Pairon, Annie Renier, Alexis Descatha, Ilir Hysi, Issam Abd-Alsamad, Marie-Annick Billon-Galland, Hélène Blons, Bénédicte Clin, Claire Danel, Denis Debrosse, Françoise Galateau-Sallé, Bruno Housset, Pierre Laurent-Puig, Françoise Le Pimpec-Barthes, Marc Letourneux, Isabelle Monnet, Jean-François Régnard, Pierre Validire, Jessica Zucman-Rossi, Marie-Claude Jaurand & Didier Jean. (2013) Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma. Mutagenesis 28:3, pages 323-331.
Crossref
Doua Bakry & David Malkin. 2013. p53 in the Clinics. p53 in the Clinics 167 188 .
HUNG-YU LIN, CHUN-HSIUNG HUANG, TSAN-JUNG YU, WEN-JEN WU, MING-CHANG YANG & FOR-WEY LUNG. (2012) p53 codon 72 polymorphism as a progression index for bladder cancer. Oncology Reports 27:4, pages 1193-1199.
Crossref
Cosmeri Rizzato, Dominique Scherer, Peter Rudnai, Eugen Gurzau, Kvetoslava Koppova, Kari Hemminki, Federico Canzian, Rajiv Kumar & Daniele Campa. (2011) POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors. Journal of Dermatological Science 63:1, pages 47-54.
Crossref
Anne M. Horgan, Boming Yang, Abul Kalam Azad, Eitan Amir, Thomas John, David W. Cescon, Paul Wheatley-Price, Rayjean J. Hung, Frances A. Shepherd & Geoffrey Liu. (2011) Pharmacogenetic and Germline Prognostic Markers of Lung Cancer. Journal of Thoracic Oncology 6:2, pages 296-304.
Crossref
Emina J. Malisic, Radmila N. Jankovic & Sinisa S. Radulovic. (2010) An intronic variant in the TP53 gene in Serbian women with cervical or ovarian cancer. Cancer Genetics and Cytogenetics 198:2, pages 173-175.
Crossref
J Chang-Claude, C B Ambrosone, C Lilla, S Kropp, I Helmbold, D von Fournier, W Haase, M-L Sautter-Bihl, F Wenz, P Schmezer & O Popanda. (2009) Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. British Journal of Cancer 100:10, pages 1680-1686.
Crossref
Roman Hrstka, Philip J. Coates & Borivoj Vojtesek. (2009) Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment. Journal of Cellular and Molecular Medicine 13:3, pages 440-453.
Crossref
Catherine Whibley, Paul D. P. Pharoah & Monica Hollstein. (2009) p53 polymorphisms: cancer implications. Nature Reviews Cancer 9:2, pages 95-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.